NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/07/2025
Back to search
Official data from USPTO
P PHARMANUTRA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
01/07/2025
Trademark type
Combined
Nice classes
5, 35
Filing date
12/20/2023
Registration date
01/07/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/07/2025
Last transaction
01/07/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
12/31/2022
First use in commerce
09/30/2023
Drawing code
3
Owner type
99
Owner location
PISA (PI), IT
Examiner
CROWDER-SCHAEFER, ANDREW W
Law office
L40
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized word "PHARMANUTRA" with a stylized "P" to the left of the word. The "P" is formed by overlapping crescents with a shaded circle in the middle of the "P".
Holders and representatives
Holders
PHARMANUTRA S.P.A.
Representatives
Michelle E. Tochtrop Chrisman Gallo Tochtrop LLC
Technical classification
Nice Classes
Class 5Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Parapharmaceutical products for the treatment of immunologic diseases and conditionsosteo-articular diseases and conditionspaininflammationfatigueimmune supportlactation supportvitamin and mineral deficiency; nutritional supplements for support of immunologic diseases and conditionsosteo-articular diseases and conditionspaininflammationfatigueimmune supportlactation supportvitamin and mineral deficiency; dietary and nutritional supplementsincluding dietary and nutritional supplements containing at least one of the following compoundsomega-3omega-6DHAfatty acidsproteinsliposomesvitaminsmineral saltsironcalciumbiotinfolic acidmicroorganismslactic bacteria and prebiotic fibers; food supplements for medical use; vitamin and mineral supplements; medicinal gelsoilscreamsointments and medicated lotions being medical preparations for treating painskin disorders; medical transdermal adhesive tapes; adhesive tapes for medical purposes
Class 35
Retail store services featuring parapharmaceuticalsnutritional supplementsmedical tapes and bandages; wholesale store services featuring parapharmaceuticalsnutritional supplementsmedical tapes and bandages
Publications
History of USPTO decisions and trademark events.
25 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/07/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/10/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/10/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/10/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/10/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/10/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/10/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/19/2024
PUBO
PUBLISHED FOR OPPOSITION
11/19/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/13/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/10/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
10/10/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/10/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
10/10/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/10/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/04/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/04/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/10/2024
GNRT
NON-FINAL ACTION E-MAILED
07/10/2024
CNRT
NON-FINAL ACTION WRITTEN
07/10/2024
DOCK
ASSIGNED TO EXAMINER
07/03/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/01/2024
NWAP
NEW APPLICATION ENTERED
12/20/2023
Continuous trademark protection
Get notified about every new filing that threatens P PHARMANUTRA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.